{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:46:47Z","timestamp":1790383607509,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jaad.2020.01.036","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T21:45:17Z","timestamp":1579902317000},"page":"1205-1212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Cannabinoids for the treatment of chronic pruritus: A review"],"prefix":"10.1016","volume":"82","author":[{"given":"Christina","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Massick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bechtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jaad.2020.01.036_bib1","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archdermatol.2011.178","article-title":"The impact of pruritus on quality of life: the skin equivalent of pain","volume":"147","author":"Kini","year":"2011","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.01.036_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000319862","article-title":"Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730","volume":"221","author":"St\u00e4nder","year":"2010","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.jaad.2020.01.036_bib3","first-page":"178","article-title":"Chronic pruritus in Turkish dermatology outpatients: prevalence, sociodemographic and clinical characteristics","volume":"151","author":"Sarikaya Solak","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2020.01.036_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2340\/00015555-2166","article-title":"Prevalence and characteristics of pruritus: a one-week cross-sectional study in a German dermatology practice","volume":"96","author":"Kopyciok","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2020.01.036_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728214.2015.1051964","article-title":"Emerging drugs for the treatment of pruritus","volume":"20","author":"St\u00e4nder","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"issue":"17","key":"10.1016\/j.jaad.2020.01.036_bib6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","article-title":"Clinical practice. Chronic pruritus","volume":"68","author":"Yosipovitch","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jaad.2020.01.036_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1774-9987.2005.00271.x","article-title":"Emollients with endocannabinoids in the treatment of uremic pruritus: discussion of the therapeutic options","volume":"9","author":"Szepietowski","year":"2005","journal-title":"Ther Apher Dial"},{"issue":"9","key":"10.1016\/j.jaad.2020.01.036_bib8","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/CIA.S65448","article-title":"N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients","volume":"17","author":"Yuan","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"5","key":"10.1016\/j.jaad.2020.01.036_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2340\/00015555-2593","article-title":"Efficacy of body lotion containing N-palmitoylethanolamine in subjects with chronic pruritus due to dry skin: a dermatocosmetic study","volume":"97","author":"Visse","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2020.01.036_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00011-003-1162-z","article-title":"Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin","volume":"52","author":"Dvorak","year":"2003","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.jaad.2020.01.036_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/ja00730a036","article-title":"The isolation and structure of \u0394-tetrahydrocannabinol and other neutral cannabinoids from hashish","volume":"93","author":"Gaoni","year":"1971","journal-title":"J Am Chem Soc"},{"issue":"11","key":"10.1016\/j.jaad.2020.01.036_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.jaad.2020.01.036_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5152\/eurjrheum.2017.17025","article-title":"The endocannabinoid system in pain and\u00a0inflammation: its relevance to rheumatic disease","volume":"4","author":"Barrie","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.jaad.2020.01.036_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2017.06.015","article-title":"The cannabinoid system and pain","volume":"124","author":"Woodhams","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jaad.2020.01.036_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bcp.2018.08.022","article-title":"The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders","volume":"157","author":"R\u00edo","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.jaad.2020.01.036_bib16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/cn5000919","article-title":"TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation","volume":"5","author":"Caterina","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jaad.2020.01.036_bib17","author":"Baumann"},{"issue":"10","key":"10.1016\/j.jaad.2020.01.036_bib18","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1111\/ijd.12841","article-title":"Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model","volume":"54","author":"Kim","year":"2015","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.01.036_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5021\/ad.2016.28.1.22","article-title":"Selective cannabinoid receptor-1 agonists regulate mast cell activation in an oxazolone-induced atopic dermatitis model","volume":"28","author":"Nam","year":"2016","journal-title":"Ann Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.01.036_bib20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.jaad.2020.01.036_bib21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2013.01.002","article-title":"Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ","volume":"132","author":"Sugawara","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2020.01.036_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2005.01.007","article-title":"Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin","volume":"38","author":"St\u00e4nder","year":"2005","journal-title":"J Dermatol Sci"},{"issue":"8","key":"10.1016\/j.jaad.2020.01.036_bib23","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.bmcl.2012.02.072","article-title":"Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent","volume":"22","author":"Odan","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.jaad.2020.01.036_bib24","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/jid.2011.87","article-title":"Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models","volume":"131","author":"Yun","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.01.036_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00213-011-2224-5","article-title":"CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action","volume":"216","author":"Schlosburg","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.jaad.2020.01.036_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0304-3959(01)00454-7","article-title":"CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain","volume":"96","author":"Clayton","year":"2002","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jaad.2020.01.036_bib27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.108.150136","article-title":"Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus","volume":"329","author":"Schlosburg","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"6690","key":"10.1016\/j.jaad.2020.01.036_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jaad.2020.01.036_bib29","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0028-3908(02)00040-0","article-title":"The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats","volume":"42","author":"Ellington","year":"2002","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.jaad.2020.01.036_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/epi.13973","article-title":"Cannabinoids for epilepsy: what do we know and where do we go?","volume":"59","author":"Brodie","year":"2018","journal-title":"Epilepsia"},{"issue":"24","key":"10.1016\/j.jaad.2020.01.036_bib31","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/jama.2015.6199","article-title":"Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review","volume":"313","author":"Hill","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jaad.2020.01.036_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2222.2011.03791.x","article-title":"Basic mechanisms of itch","volume":"42","author":"Potenzieri","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaad.2020.01.036_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000446011","article-title":"Central mechanisms of itch","volume":"50","author":"Carstens","year":"2016","journal-title":"Curr Probl Dermatol"},{"issue":"1-2","key":"10.1016\/j.jaad.2020.01.036_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000371890","article-title":"S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission","volume":"95","author":"Haruna","year":"2015","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.jaad.2020.01.036_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.aat.2013.10.004","article-title":"Targeting the cannabinoid system for pain relief?","volume":"51","author":"Chiou","year":"2013","journal-title":"Acta Anaesthesiol Taiwan"},{"issue":"5","key":"10.1016\/j.jaad.2020.01.036_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/ced.13398","article-title":"Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist","volume":"43","author":"Bilir","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"21","key":"10.1016\/j.jaad.2020.01.036_bib37","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/S0024-3205(03)00668-4","article-title":"The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis","volume":"73","author":"Gingold","year":"2003","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jaad.2020.01.036_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB 2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.jaad.2020.01.036_bib39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s13238-017-0395-5","article-title":"TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization","volume":"8","author":"Gouin","year":"2017","journal-title":"Protein Cell"},{"issue":"4","key":"10.1016\/j.jaad.2020.01.036_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ph11040100","article-title":"TRP channels as drug targets to relieve itch","volume":"11","author":"Xie","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jaad.2020.01.036_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid ligands targeting TRP channels","volume":"11","author":"Muller","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.jaad.2020.01.036_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrd2757","article-title":"Transient receptor potential channels: targeting pain at the source","volume":"8","author":"Patapoutian","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"27","key":"10.1016\/j.jaad.2020.01.036_bib43","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1073\/pnas.0905605106","article-title":"TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms","volume":"106","author":"Imamachi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.jaad.2020.01.036_bib44","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1523\/JNEUROSCI.4643-06.2007","article-title":"TRPV1 Mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase","volume":"27","author":"Shim","year":"2007","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jaad.2020.01.036_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/jpet.102.040675","article-title":"Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes","volume":"304","author":"Southall","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.jaad.2020.01.036_bib46","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tins.2010.09.002","article-title":"The multiple pathways for itch and their interactions with pain","volume":"33","author":"Davidson","year":"2010","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/j.jaad.2020.01.036_bib47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nn.2789","article-title":"TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch","volume":"14","author":"Wilson","year":"2011","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.jaad.2020.01.036_bib48","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bph.12029","article-title":"Activation and desensitization of TRPV1 channels in sensory neurons by the PPAR\u03b1 agonist palmitoylethanolamide","volume":"168","author":"Ambrosino","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2020.01.036_bib49","article-title":"Cannabinoids in dermatology: a scoping review","volume":"24","author":"Eagleston","year":"2018","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.jaad.2020.01.036_bib50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/cells3020517","article-title":"TRPV1: a potential drug target for treating various diseases","volume":"3","author":"Brito","year":"2014","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.jaad.2020.01.036_bib51","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"Pt 2","key":"10.1016\/j.jaad.2020.01.036_bib52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/BJ20041682","article-title":"Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells","volume":"388","author":"Small-Howard","year":"2005","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.jaad.2020.01.036_bib53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2011.11.009","article-title":"Endocannabinoids limit excessive mast cell maturation and activation in human skin","volume":"129","author":"Sugawara","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2020.01.036_bib54","first-page":"97","article-title":"Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a\u00a0preliminary study","volume":"13","author":"Szepietowski","year":"2005","journal-title":"Acta Dermatovenerol Croat"},{"issue":"8","key":"10.1016\/j.jaad.2020.01.036_bib55","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1572-0241.2002.05852.x","article-title":"Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease","volume":"97","author":"Neff","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jaad.2020.01.036_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","article-title":"Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)","volume":"22","author":"Eberlein","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2020.01.036_bib57","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00105-006-1180-1","article-title":"Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus","volume":"57","author":"St\u00e4nder","year":"2006","journal-title":"Hautarzt"},{"issue":"2","key":"10.1016\/j.jaad.2020.01.036_bib58","first-page":"80","article-title":"Topical adelmidrol 2% emulsion, a novel aliamide, in the treatment of mild atopic dermatitis in pediatric subjects: a pilot study","volume":"15","author":"Pulvirenti","year":"2007","journal-title":"Acta Dermatovenerol Croat"},{"issue":"5","key":"10.1016\/j.jaad.2020.01.036_bib59","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0190-9622(03)02478-2","article-title":"Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease","volume":"49","author":"Zucker","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.01.036_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000446010","article-title":"Epidemiology of itch","volume":"50","author":"Weisshaar","year":"2016","journal-title":"Curr Probl Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2020.01.036_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23102478","article-title":"Cannabinoid delivery systems for pain and inflammation treatment","volume":"23","author":"Bruni","year":"2018","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.jaad.2020.01.036_bib62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpain.2007.12.010","article-title":"A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain","volume":"9","author":"Wilsey","year":"2008","journal-title":"J Pain"},{"issue":"2","key":"10.1016\/j.jaad.2020.01.036_bib63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/00325481.2018.1413281","article-title":"Vaping medical marijuana","volume":"130","author":"Singh","year":"2018","journal-title":"Postgrad Med"},{"issue":"36","key":"10.1016\/j.jaad.2020.01.036_bib64","doi-asserted-by":"crossref","first-page":"787","DOI":"10.15585\/mmwr.mm6836e2","article-title":"Severe pulmonary disease associated with electronic-cigarette-product use\u2014interim guidance","volume":"68","author":"Schier","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.jaad.2020.01.036_bib65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/all.13043","article-title":"Cannabis sativa allergy: looking through the fog","volume":"72","author":"Decuyper","year":"2017","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.jaad.2020.01.036_bib66","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuropharm.2012.05.032","article-title":"Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs. spinally-innervated skin","volume":"63","author":"Spradley","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.jaad.2020.01.036_bib68","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1203475418808761","article-title":"Dermatology-related uses of medical cannabis promoted by dispensaries in Canada, Europe, and the United States","volume":"23","author":"Lim","year":"2019","journal-title":"J Cutan Med Surg"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220301201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220301201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:53:03Z","timestamp":1759272783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220301201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0190962220301201"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.01.036","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids for the treatment of chronic pruritus: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}